Park Square Financial Group, LLC Vericel Corp Transaction History
Park Square Financial Group, LLC
- $145 Billion
- Q4 2024
A detailed history of Park Square Financial Group, LLC transactions in Vericel Corp stock. As of the latest transaction made, Park Square Financial Group, LLC holds 127 shares of VCEL stock, worth $5,651. This represents 0.0% of its overall portfolio holdings.
Number of Shares
127Holding current value
$5,651% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding VCEL
# of Institutions
292Shares Held
49.4MCall Options Held
98.2KPut Options Held
135K-
Black Rock Inc. New York, NY8.06MShares$359 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.49MShares$155 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD3.24MShares$144 Million4.21% of portfolio
-
State Street Corp Boston, MA2.4MShares$107 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA2.24MShares$99.6 Million0.02% of portfolio
About Vericel Corp
- Ticker VCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,178,000
- Market Cap $2.1B
- Description
- Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...